下载 - 辅料中国

Novartis AG (Patent
Assignee/Owner)
Novartis AG (Patent
Assignee/Owner);
Novartis Pharma GmbH
[Novartis AG] (Patent
Assignee/Owner)
Novartis Pharma GmbH
[Novartis AG] (Patent
Assignee/Owner)
Novartis Pharma GmbH
[Novartis AG] (Patent
Assignee/Owner)
Novartis Pharma GmbH
[Novartis AG] (Patent
Assignee/Owner)
Novartis AG (Patent
Assignee/Owner);
Novartis Pharma GmbH
[Novartis AG] (Patent
Assignee/Owner)
Novartis Pharma GmbH
[Novartis AG] (Patent
Assignee/Owner)
Novartis Pharma GmbH
[Novartis AG] (Patent
Assignee/Owner)
Novartis-Erfindungen
Verwaltungsgesellschaft
mbH [Novartis AG]
(Patent
Assignee/Owner)
Novartis Pharma GmbH
[Novartis AG] (Patent
Assignee/Owner)
Novartis-Erfindungen
Verwaltungsgesellschaft
mbH [Novartis AG]
18
www.pharmadl.com
Combinations of valsartan with COX-2 inhibitors WO-2004054575
( 18-DEC-2002 )
Process for the manufacture of valsartan WO-2004026847
( 23-SEP-2002 )
Use of organic compounds WO-2004002549
( 28-JUN-2002 )
Combination of a DPP IV inhibitor and a
cardiovascular compound
Combination of angiotensin II receptor blocker and
beta-blocker for secondary prevention of
myocardial infarction
Use of valsartan ot its metabolite to inhibit platelet
aggregation
WO-03099279
( 29-MAY-2002 )
WO-03097099
( 17-MAY-2002 )
WO-03094915
( 14-MAY-2002 )
Salts of valsartan WO-03066606
( 04-FEB-2002 )
Pharmaceutical compositions comprising valsartan
and NEP inhibitors
Synergistic combinations comprising a renin
inhibitor for cardiovascular diseases
WO-03059345
( 17-JAN-2002 )
WO-00240007
( 15-NOV-2001 )
Organic compounds WO-03035046
( 18-OCT-2001 )
Combinations WO-03028730
( 27-SEP-2001 )
上海数图健康医药科技有限公司
Combination
Component
of
Combination
Process
Component
of
Combination;
Delivery
device
Component
of
Combination
Component
of
Combination
New use
Product
(derivative)
Component
of
Combination
Component
of
Combination
Component
of
Combination;
Product
(derivative)
Component
of
Combination